CBLL saw its Momentum Indicator move above the 0 level on November 09, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator turned positive. In 28 of the 31 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Following a +6.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBLL advanced for three days, in 97 of 113 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The 10-day RSI Indicator for CBLL moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In 10 of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for CBLL turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 11 similar instances when the indicator turned negative. In 10 of the 11 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
CBLL broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.955) is normal, around the industry mean (4.142). P/E Ratio (-15.108) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (9.009) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CBLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBLL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NPCE saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned negative. In 88 of the 98 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NPCE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
NPCE broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NPCE entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NPCE's RSI Oscillator exited the oversold zone, 23 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 56 cases where NPCE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for NPCE just turned positive on November 04, 2026. Looking at past instances where NPCE's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
Following a +0.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where NPCE advanced for three days, in 236 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NPCE's P/B Ratio (36.106) is slightly higher than the industry average of (4.142). P/E Ratio (-21.930) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (4.427) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. NPCE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NPCE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
| CBLL | NPCE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 3 days ago 90% |
| Stochastic ODDS (%) | 1 day ago 86% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 86% |
| Advances ODDS (%) | 4 days ago 86% | 17 days ago 85% |
| Declines ODDS (%) | 8 days ago 78% | 1 day ago 88% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 86% |
| Aroon ODDS (%) | N/A | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBLL’s FA Score shows that 1 FA rating(s) are green while NPCE’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBLL’s TA Score shows that 2 TA indicator(s) are bullish while NPCE’s TA Score has 4 bullish TA indicator(s).
CBLL (@Medical/Nursing Services) experienced а +1.50% price change this week, while NPCE (@Medical/Nursing Services) price change was -6.15% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
NPCE is expected to report earnings on Nov 12, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CBLL has been loosely correlated with BFLY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CBLL jumps, then BFLY could also see price increases.
| Ticker / NAME | Correlation To CBLL | 1D Price Change % | ||
|---|---|---|---|---|
| CBLL | 100% | +1.16% | ||
| BFLY - CBLL | 39% Loosely correlated | +9.68% | ||
| NPCE - CBLL | 37% Loosely correlated | -1.34% | ||
| SGHT - CBLL | 35% Loosely correlated | +1.58% | ||
| PACB - CBLL | 35% Loosely correlated | -6.70% | ||
| CERS - CBLL | 33% Loosely correlated | +8.72% | ||
More | ||||
A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with LIVN. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then LIVN could also see price increases.
| Ticker / NAME | Correlation To NPCE | 1D Price Change % | ||
|---|---|---|---|---|
| NPCE | 100% | -1.34% | ||
| LIVN - NPCE | 54% Loosely correlated | -0.18% | ||
| OFIX - NPCE | 43% Loosely correlated | +0.84% | ||
| IRMD - NPCE | 42% Loosely correlated | -0.16% | ||
| IART - NPCE | 41% Loosely correlated | +1.65% | ||
| UFPT - NPCE | 39% Loosely correlated | +0.00% | ||
More | ||||